In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by Merck. Ivonescimab reduced risk of tumour progression by 49%.

The China-based trial enrolled 398 patients who were randomised to the ivonescimab and Keytruda arms at a one-to-one ratio.

The approval for the KEYTRUDA regimen is supported by results from the Phase II/III IND.227/KEYNOTE-483 trial.

And certainly, our two key drivers have been KEYTRUDA and GARDASIL. And when I look at KEYTRUDA ... So really excited with sotatercept, WINREVAIR is its brand name. We received the approval. We're ...

Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

along with the immunotherapy drug, Keytruda, that is already a blockbuster for Merck. The study will assess the efficiency of the treatment that Moderna and Merck created in achieving a recurrence ...

Avery Dennison Corporation , a leading global materials science and digital identification solutions company, will speak to the investment community during its 2024 Investor Day today in New York, NY.

TELUS Digital Experience (TELUS Digital) officially launched its global rebrand today, transitioning from TELUS International to TELUS Digital. The new name reflects the company's commitment to ...